.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2013 for a whopping $43 ...
.On the heels of a phase 3 succeed that fell short to impress capitalists, Ironwood Pharmaceuticals ...
.Do not quit Monte Rosa Rehabs now. The Boston-based biotech is enjoying after authorizing a handle ...
.Welcome to recently's Chutes & Ladders, our summary of notable leadership hirings, firings as we...
.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer called the positi...
.AbbVie has actually come back to the resource of its antipsychotic giant Vraylar in search of an ad...
.GenSight Biologics is actually weeks far from losing money. Once more. The biotech only possesses a...
.Monopar Rehabs is actually bouncing back a medicine coming from the scrap heap of AstraZeneca's rar...
.Along with new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of expert...
.After forming a gene therapy alliance along with Dyno Rehabs in 2020, Roche is back for more.In a n...